ClinicalTrials.Veeva

Menu

Reproducibility of RNFL Circle Scans With ART-Function of Heidelberg Spectralis SD-OCT Software Version 5.3

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Unknown

Conditions

Glaucoma Patients and Healthy Controls

Treatments

Device: Spectralis® SD-OCT, Heidelberg Engineering GmbH, H

Study type

Observational

Funder types

Other

Identifiers

NCT01299233
ART-OCT

Details and patient eligibility

About

To assess the improvement in reproducibility of 100 vs. 16 averaged images by Automatic Real Time (ART) using Spectralis™ Spectral Domain-Optical Coherence Tomography (SD-OCT, Heidelberg Engineering GmbH, Heidelberg, Germany) in retinal nerve fiber layer thickness (RNFL) circle scan-measurements.

  • Trial with medical device

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

for both groups (glaucoma study group and control group): men and women of at least 50 years of age

for the glaucoma study group: diagnosis of primary open angle glaucoma (POAG)

Exclusion criteria

for both groups (glaucoma study group and control group):

  • less then 18 years of age
  • any pathology of the central retina
  • any optic nerve disorder other then glaucoma
  • retinal vascular disorder

for the glaucoma study group: other glaucoma diagnosis then primary open angle glaucoma

for the control group: any diagnosis of glaucoma

Trial design

100 participants in 2 patient groups

control group
Description:
age matched healthy controls
Treatment:
Device: Spectralis® SD-OCT, Heidelberg Engineering GmbH, H
Glaucoma
Description:
patients with diagnosis of primary open angle glaucoma
Treatment:
Device: Spectralis® SD-OCT, Heidelberg Engineering GmbH, H

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems